1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Drug Discovery and Development

Drug Discovery & Development Sector: Latest Market Trends and Statistics

  • Currently 3/5 Stars.
  • 1
  • 2
  • 3
  • 4
  • 5
13 votes

Topics under Drug Discovery and Development

Global Drug Discovery and Development Industry

The global drug discovery and development industry (part of the wider pharmaceutical industry) involves the discovery and design of drugs through laboratory testing to treat disease and infection. With costs running high and few drugs making it to the market, drug discovery and development leaders are constantly seeking ways to reduce expenditure and boost efficiency.

One option companies frequently avail of is the practice of outsourcing sections of the discovery and development process. The global drug discovery outsourcing market is expected to grow from less than $7.5 billion in 2009 to a forecast worth of $18.5 billion in 2015, according to Business Insights. Meanwhile, the global drug discovery technologies market is expected to be worth more than $32 billion by 2012, growing at an annual compound rate in excess of 8%.

The industry requires heavy investment with no guarantee of results, including under 1% of discoveries going on to be approved by the US Food and Drug Administration. The process itself can take between 12 and 20 years, and cost over the $1.2 billion mark, reports the Alfred Mann Foundation for Biomedical Engineering.

Leading Market Segments

It is estimated that high throughput screening will be worth $12 billion by 2012, showing over 7% growth in the preceding five years.

Bioanalytical instruments have a forecast worth of $10.5 billion in 2012, demonstrating growth in excess of 9%. It is believed the segment of other technologies should come close to the $4.5 billion mark in 2012. Business Insights estimates the electronic data capture market for clinical trials will pass the $1 billion mark in 2016 at 13% annual growth.

Process: Drug Testing and Development

The steps involved in drug discovery begin with the identification of targets, which are genetic or cellular chemicals that influence disease. Once the target has been isolated, the compounds that may work best on them can in turn be determined. Next, the chosen target’s capacity to act on diseased cells is observed before compounds necessary to create a drug are determined, along with the drug target’s response to the compound. In the next phase compounds are compared and data is compiled to aid biopharmaceutical companies to determine the most promising compound for drug creation.

Once a drug has been designed, it enters the preclinical phase of development in which it is tested for up to five years to establish its impact on cells. The drug also undergoes toxicology testing to determine any possible harm to humans. In the clinical phase, drugs are administered to humans to test efficacy and potential side effects before companies seek authorization to market the new drug. Research compiled throughout the process is submitted to the relevant authority as the company awaits approval; this part of the process can last up to two years.

Contract Research Organization (CRO) Market Value (2005 - 2010) 

Read more »

Share

You might be interested in these related markets:

24/7 Customer Support

Talk to Sam

+44 208 068 8943

1-10 of about 500 reports

Drug Discovery And Development Industry in the US and Australia

  • May 2017
    5 pages
  • Drug Discovery ...  

  • United States  

    Australia  

View report >

Drug Discovery And Development Industry in Europe - Forecast

  • January 2017
    5 pages
  • Drug Discovery ...  

  • Europe  

View report >

Drug Discovery And Development Industry in the UK

  • September 2017
    8 pages
  • Drug Discovery ...  

  • United Kingdom  

View report >

Drug Discovery And Development Forecast Statistics in India, Weekly Update

  • January 2017
    8 pages
  • Drug Discovery ...  

  • India  

    World  

View report >

Drug Discovery And Development Industry in Australia and the US

  • November 2016
    6 pages
  • Drug Discovery ...  

  • Australia  

    United States  

View report >

The future of the Clinical Trial Industry in Australia

  • September 2017
    2 pages
  • Clinical Trial  

    Health Care Pro...  

  • Australia  

    Oceania  

View report >

Clinical Trial Industry in China - Forecast

  • August 2017
    5 pages
  • Clinical Trial  

  • China  

View report >

Clinical Trial Industry in China - Forecast

  • August 2017
    5 pages
  • Clinical Trial  

  • China  

View report >

Search in Drug Discovery And Development Industry (About 500 reports)
Parent industry: Pharmaceutical
Related industries: Drug Delivery, Generic Drug, OTC, Pharmacy, Prescription Drug, Therapy

About 2100 reports

Purchase Reports From Reputable Market Research Publishers
(From € 270 - € 17390)

Anti-Knock Preparation Markets in the World to 2021 - Market Size, Development, and Forecasts

  • € 17390
  • Industry report
  • July 2017
  • by Global Research & Data Services

The report package Anti-Knock Preparation Markets in the World to 2021 - Market Size, Development, and Forecasts offers the most up-to-date industry data on the actual market situation, and future outlook ...

Opportunityanalyzer: Ovarian Cancer - Opportunity Analy ...

May 2017 € 9995

Pharmapoint: Her2-negative/hr+ And Triple Negative Brea ...

December 2016 € 9995

Pharmapoint: Hepatitis C Virus (hcv) Therapeutics - Glo ...

December 2016 € 9995

Anti-knock Preparation Markets In Europe To 2021 - Mark ...

July 2017 € 9090

Pharmafocus: Tauopathies - Global Market Analysis

February 2017 € 8632

Anti-knock Preparation Markets In Asia To 2021 - Market ...

July 2017 € 6790

Anti-knock Preparation Markets In Eastern Europe To 202 ...

July 2017 € 6590

Clinical Trial Management System Market By End-user, De ...

August 2016 € 5045

Eclinical Solutions Market By Product, Delivery Mode, C ...

April 2017 € 5045

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.